TD

Tao Dao

MC Memorial Sloan Kettering Cancer Center: 11 patents #28 of 761Top 4%
ET Eureka Therapeutics: 8 patents #10 of 40Top 25%
📍 New York, NY: #1,732 of 20,192 inventorsTop 9%
🗺 New York: #13,384 of 115,490 inventorsTop 15%
Overall (All Time): #440,060 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
11859015 Immunogenic WT-1 peptides and methods of use thereof David A. Scheinberg 2024-01-02
11505599 T cell receptor-like antibodies specific for Foxp3-derived peptides David A. Scheinberg, Cheng Liu 2022-11-22
11384144 T cell receptor-like antibodies specific for a PRAME peptide David A. Scheinberg, Cheng Liu, Hong Liu, Yiyang Xu, Su Yan 2022-07-12
11242405 Monoclonal antigen-binding proteins to intracellular oncogene products David A. Scheinberg, Cheng Liu 2022-02-08
10858444 T cell receptor-like antibodies specific for a WTI peptide presented by HLA-A2 David A. Scheinberg, Cheng Liu, Su Yan 2020-12-08
10815273 Immunogenic WT-1 peptides and methods of use thereof David A. Scheinberg 2020-10-27
10239952 Anti-WT1/HLA bi-specific antibody David A. Scheinberg, Jingyi Xiang, Su Yan, Cheng Liu 2019-03-26
10040865 T cell receptor-like antibodies specific for a WTI peptide presented by HLA-A2 David A. Scheinberg, Cheng Liu, Su Yan 2018-08-07
9919037 Immunogenic WT-1 peptides and methods of use thereof David A. Scheinberg 2018-03-20
9540448 T cell receptor-like antibodies specific for a WTI peptide presented by HLA-A2 David A. Scheinberg, Cheng Liu, Su Yan 2017-01-10
9074000 T cell receptor-like antibodies specific for a WT1 peptide presented by HLA-A2 David A. Scheinberg, Cheng Liu, Su Yan 2015-07-07